🟢 Alvotech is trading 3.81% up today FDA approval doubles U.S. SIMLANDI production capacity

Alvotech is trading 3.81% up at ISK 708.00, alongside news that the FDA approved a second Reykjavik production suite for U.S. SIMLANDI supply.

• The approval was announced on October 5, 2026; Alvotech says the added suite effectively doubles manufacturing capacity available to support that supply.
• The announcement did not report a share-price reaction, and no trading volume was provided.